Objective: We performed a systematic review of the literature and meta-analysis on the efficacy and safety of hydroxychloroquine to treat COVID-19 patients
Cochrane Evidence Synthesis and Methods Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection
Getty Images There are doubts about its effectiveness as a treatment There's been widespread interest in hydroxychloroquine as both a preventative measure and
Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) Funder: The National Heart, Lung, and
The NIH COVID-19 Treatment Guidelines were frequently updated as published data and other authoritative information became available
More than a year after catching COVID-19, Sawyer Blatz still can’t practice his weekly rituals: running for miles in San Francisco’s Golden Gate Park or biking
In their comment about Hydroxychloroquine and “COPE”1 (the largest RCT so far on Hydroxychloroquine for early treatment of COVID-19), Schwartz et al
Infect
We sear
Background: Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV)
At this time of the COVID-19 global pandemic, potentially effective treatments are currently under urgent investigation
In this review, we critically examine
Both drugs are FDA approved for other diseases and can be taken safely as directed by a doctor
It is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV-2), which causes severe pneumonia leading to fatal respiratory failure ()
These tests look for genetic material from the COVID-19 virus
President Trump has repeatedly promoted the anti-malarial drug as a The rapid spread of virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency
Hydroxychloroquine (HCQ), also known by its trade name Plaquenil®, has been used for over 50 years as a treatment for malaria, systemic lupus erythematosus, and rheumatoid arthritis
Hydroxychloroquine and chloroquine have garnered unprecedented attention as potential therapeutic agents against COVID-19 following several small clinical trials, uncontrolled